| Both sides previous revision Previous revision Next revision | Previous revision |
| meibomiantitis [2026/07/28 12:46] – [References] Scott Larson | meibomiantitis [2026/08/06 21:07] (current) – [Meibomianitis (Meibomitis): Causes and Treatments] Scott Larson |
|---|
| |
| - [[https://pubmed.ncbi.nlm.nih.gov/34107053/|Oral Antibiotics for Chronic Blepharitis. Onghanseng N, Ng SM, Halim MS, Nguyen QD. The Cochrane Database of Systematic Reviews. 2021;6:CD013697]] | - [[https://pubmed.ncbi.nlm.nih.gov/34107053/|Oral Antibiotics for Chronic Blepharitis. Onghanseng N, Ng SM, Halim MS, Nguyen QD. The Cochrane Database of Systematic Reviews. 2021;6:CD013697]] |
| - [[Dry Eye. Clayton JA. The New England Journal of Medicine. 2018;378(23):2212-2223]] doi:10.1056/NEJMra1407936 | - [[https://www-nejm-org.slhs.idm.oclc.org/doi/full/10.1056%2FNEJMra1407936|Dry Eye. Clayton JA. The New England Journal of Medicine. 2018;378(23):2212-2223]] |
| - [[https://pubmed.ncbi.nlm.nih.gov/30481812/|Inflamed Obstructive Meibomian Gland Dysfunction Causes Ocular Surface Inflammation. Suzuki T. Investigative Ophthalmology & Visual Science. 2018;59(14):DES94-DES101]] | - [[https://pubmed.ncbi.nlm.nih.gov/30481812/|Inflamed Obstructive Meibomian Gland Dysfunction Causes Ocular Surface Inflammation. Suzuki T. Investigative Ophthalmology & Visual Science. 2018;59(14):DES94-DES101]] |
| - Molecular Mechanisms and Pathophysiology of Meibomian Gland Dysfunction. Yang L, Li Z. Experimental Eye Research. 2026;267:110970. doi:10.1016/j.exer.2026.110970. | - [[https://pubmed.ncbi.nlm.nih.gov/41831668/|Molecular Mechanisms and Pathophysiology of Meibomian Gland Dysfunction. Yang L, Li Z. Experimental Eye Research. 2026;267:110970]] |
| - A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland Dysfunction. Tauber J. Cornea. 2020;39(4):403-407. doi:10.1097/ICO.0000000000002235. | - [[https://pubmed.ncbi.nlm.nih.gov/31895884/|A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland Dysfunction. Tauber J. Cornea. 2020;39(4):403-407]] |
| - Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review. Cooper JM, Mahmoud R, Jennings CJ, et al. Drugs. 2026;86(5):675-718. doi:10.1007/s40265-025-02241-6. | - [[https://pubmed.ncbi.nlm.nih.gov/41931217/|Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review. Cooper JM, Mahmoud R, Jennings CJ, et al. Drugs. 2026;86(5):675-718]] |
| - Pulsed Oral Azithromycin vs 6-Week Oral Doxycycline for Moderate to Severe Meibomian Gland Dysfunction: A Randomized Clinical Trial. Upaphong P, Tangmonkongvoragul C, Phinyo P. JAMA Ophthalmology. 2023;141(5):423-429. doi:10.1001/jamaophthalmol.2023.0302. | - [[https://pmc.ncbi.nlm.nih.gov/articles/PMC10037201/#eoi230007f1|Pulsed Oral Azithromycin vs 6-Week Oral Doxycycline for Moderate to Severe Meibomian Gland Dysfunction: A Randomized Clinical Trial. Upaphong P, Tangmonkongvoragul C, Phinyo P. JAMA Ophthalmology. 2023;141(5):423-429]] |
| - Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Wladis EJ, Bradley EA, Bilyk JR, Yen MT, Mawn LA. Ophthalmology. 2016;123(3):492-6. doi:10.1016/j.ophtha.2015.10.062. | - [[https://pubmed.ncbi.nlm.nih.gov/26707417/|Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Wladis EJ, Bradley EA, Bilyk JR, Yen MT, Mawn LA. Ophthalmology. 2016;123(3):492-6]]. |
| - Interventions for Dry Eye: An Overview of Systematic Reviews. McCann P, Kruoch Z, Lopez S, et al. JAMA Ophthalmology. 2024;142(1):58-74. doi:10.1001/jamaophthalmol.2023.5751. | - [[https://pmc.ncbi.nlm.nih.gov/articles/PMC11613798/|Interventions for Dry Eye: An Overview of Systematic Reviews. McCann P, Kruoch Z, Lopez S, et al. JAMA Ophthalmology. 2024;142(1):58-74]] |
| - Thermal Pulsation in the Management of Meibomian Gland Dysfunction and Dry Eye: A Report by the American Academy of Ophthalmology. Tao JP, Shen JF, Aakalu VK, et al. Ophthalmology. 2023;130(12):1336-1341. doi:10.1016/j.ophtha.2023.07.009. | - [[https://pubmed.ncbi.nlm.nih.gov/37642619/|Thermal Pulsation in the Management of Meibomian Gland Dysfunction and Dry Eye: A Report by the American Academy of Ophthalmology. Tao JP, Shen JF, Aakalu VK, et al. Ophthalmology. 2023;130(12):1336-1341]] |
| - Intense Pulsed Light (IPL) Therapy for the Treatment of Meibomian Gland Dysfunction. Cote S, Zhang AC, Ahmadzai V, et al. The Cochrane Database of Systematic Reviews. 2020;3:CD013559. doi:10.1002/14651858.CD013559. | - [[https://pmc.ncbi.nlm.nih.gov/articles/PMC7077992/|Intense Pulsed Light (IPL) Therapy for the Treatment of Meibomian Gland Dysfunction. Cote S, Zhang AC, Ahmadzai V, et al. The Cochrane Database of Systematic Reviews. 2020;3:CD013559]] |